KURE Fees and Costs — KraneShares MSCI All China Health Care Index ETF

Data updated: 2026-08-28

The net expense ratio is 0.65%: a 0.78% management fee plus 0.01% other expenses, less a 0.14% fee waiver. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $86K in broker commissions, 0.0942% of average net assets, and portfolio turnover was 73%.

KURE Fees and Expenses

Annual operating expenses and sales charges of KURE. Prospectus, as of August 1, 2026.

Annual operating expenses
Management fee0.78%
12b-1 fee0.00%
Other expenses0.01%
Gross expense ratio0.79%
Fee waiver−0.14%
Net expense ratio0.65%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentNo

KURE Costs Over Time

On $10,000 invested in KURE, assuming 5% a year before costs, total costs come to $468 over 5 years, cutting the return by 0.78% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.65%)$68$214$371
Trading costs (broker commissions)$10$31$54
Lost growth on money paid in costs$0$12$43
Total costs$78$257$468
Value after costs$10,422$11,320$12,295
Impact on return, per year0.78%0.78%0.78%

KURE Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending March 31, 2026.

  • Explicit cost rate (commissions ÷ average net assets): 0.0942%
  • Total broker commissions: $86K
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 73%
  • Securities on loan, average value: $475K
  • Net income from securities lending: $2K (0.003% of average net assets)

KURE Agency Brokers

Commissions paid.

BrokerAmountShare
J P MORGAN CHASE BANK$42K48.99%
UBS INTERNATIONAL INC$15K17.69%
MISCHLER$12K14.42%
GOLDMAN, SACHS & CO$11K12.58%
BAML$4K4.26%
SOCIETE GENERALE$1K1.46%
MACQUARIE CAPITAL$5230.61%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.